Eli Lilly and Co.

Drugmaker Eli Lilly and Co. is restricting access to a drug discount program intended for safety-net hospitals in a move the company says is needed to identify waste, fraud and abuse.

Lilly will produce next generation medicines on the campus, including for weight management, obesity and heart disease.

The announcement comes as state officials seek to address energy affordability issues.

The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.

Eli Lilly announces $7-billion merger, with eye on wakefulness drugs. The deal with London and Boston-based biotech company Centessa could have implications for treating Alzheimer’s.

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of dollars.

Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and Lilly CEO David Ricks signed a $40 million, five-year deal Wednesday.

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the workforce-talent pipeline.

The new research and development site will combine research, process development and clinical trial manufacturing capabilities into one plant.

The LillyDirect website connects people with independent telehealth providers, tailored support and other disease management resources. The website also allows patients to have some medications delivered directly to their home.